Ning Chuan's biological competitive advantage;
① Resource and cost advantages.
The issuer makes full use of the geographical and resource advantages of Yili, Xinjiang, and reduces the production cost from multiple dimensions, so that the company's products have more cost advantages in the fierce market competition. In terms of raw materials, the issuer is located near the corn producing area, with abundant sunshine and high corn protein content, and the overall production cost is relatively lower than that of mainland production enterprises.
In terms of labor cost, the average labor cost in Xinjiang is lower than the national average; The issuer also owns a coal-fired power plant and is close to the coal producing area. The cost of coal and energy in Xinjiang is relatively low, and the issuer has obvious advantages in power cost.
The publisher is located in Ili Valley, where there are climatic conditions such as temperature and humidity suitable for biological fermentation. Appropriate climatic conditions can improve the fermentation level, thus reducing the production cost of publishers.
In addition, the 500 cubic meter fermenter used by the issuer is the first in the industry, with high product output; At the same time, the issuer will improve the fermentation level and output through further technical transformation, and carry out more refined management measures for material consumption and equipment maintenance to increase production capacity and reduce costs.
To sum up, the issuer has a cost advantage in the industry by relying on excellent local resource endowments, climatic conditions and technological innovation.
② Technical advantages.
The issuer's products adopt mature technologies such as biological fermentation, extraction, enzymolysis and process control. After long-term production and research and development, we have accumulated rich experience, and reached a high level in raw material ratio, preparation selection and process control, and are still constantly optimizing and perfecting.
The publisher's core technology is built around the basic application research of fermentation industry, such as production technology, mushroom residue research, waste treatment, quality research, stability research and so on. , choose the high-tech barrier large-capacity fermentor to carry out the research and development direction of antibiotic fermentation;
Based on the principles of synthetic preparation, process amplification and optimization, safety and effectiveness research, and zero waste discharge, a complete technical system is established, thus forming a biological fermentation technology platform with source management, controllable process, stable quality and efficient results. Issuers have strong R&D capabilities and rich technical reserves, master core technical links, and can continuously realize value transformation and promotion.
At present, the issuer has more than 30 key technologies for the preparation of bio-fermented antibiotic intermediates with independent intellectual property rights, and the overall production and preparation technology of bio-fermented antibiotic intermediates is outstanding.
③ Environmental protection advantages.
The issuer attaches great importance to environmental protection, and through the continuous upgrading of environmental protection equipment, the treatment capacity of wastewater, waste gas and waste residue has reached advanced level.
Among them, high-end integrated technologies such as "imported molecular sieve runner, hydrophobic activated carbon bed and high-temperature thermal oxidation" are used to treat fermentation tail gas; The wastewater treatment adopts MVR evaporation and "ultrafiltration +DTNF+DTRO" combined membrane filtration for advanced treatment.
Advanced technologies such as "DD high voltage electron radiation" and "high temperature hydrolysis+spray drying/disc drying" have been adopted in the field of mushroom residue treatment.
Under the background that the country pays more and more attention to environmental protection and safe production, the backward production capacity of antibiotic intermediate industry is gradually eliminated, and the approval of new projects is also increasing. The issuer has formed a high environmental barrier in the antibiotic intermediate industry and has obvious advantages.